Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K4 | O95819 | 3/20 | 0.73 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.73 |
| ▸ | FLT3 | P36888 | 2/20 | 0.73 |
| ▸ | GAK | O14976 | 1/20 | 0.73 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.73 |
| ▸ | ULK1 | O75385 | 1/20 | 0.73 |
| ▸ | STK10 | O94804 | 1/20 | 0.73 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.73 |
| ▸ | LATS1 | O95835 | 1/20 | 0.73 |
| ▸ | PAK4 | O96013 | 1/20 | 0.73 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.73 |
| ▸ | LCK | P06239 | 1/20 | 0.73 |
| ▸ | CDK1 | P06493 | 1/20 | 0.73 |
| ▸ | APRT | P07741 | 1/20 | 0.73 |
| ▸ | RET | P07949 | 1/20 | 0.73 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.73 |
| ▸ | PHKG2 | P15735 | 1/20 | 0.73 |
| ▸ | NQO2 | P16083 | 1/20 | 0.73 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.73 |
| ▸ | FECH | P22830 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27044759 | 0.94 | MAP4K4 (0.68) | MAP4K4IRAK4FLT3GAKRIPK2 | |
| SCHEMBL30775090 | 0.94 | MAP4K4 (0.68) | MAP4K4IRAK4FLT3GAKRIPK2 | |
| SCHEMBL25297847 | 0.91 | MAP4K4 (0.64) | MAP4K4IRAK4FLT3GAKRIPK2 | |
| SCHEMBL29450826 | 0.91 | MAP4K4 (0.64) | MAP4K4IRAK4FLT3GAKRIPK2 | |
| SCHEMBL3842680 | 0.87 | IRAK4 (0.52) | MAP4K4IRAK4FLT3GAKRIPK2 | |
| SCHEMBL5766532 | 0.86 | MAP4K4 (0.54) | MAP4K4IRAK4FLT3GAKRIPK2 | |
| SCHEMBL5765302 | 0.85 | GAK (0.52) | MAP4K4IRAK4FLT3GAKRIPK2 | |
| Morpholine SCHEMBL5764394 | 0.85 | IRAK4 (0.52) | MAP4K4IRAK4FLT3GAKRIPK2 | |
| SCHEMBL30775118 | 0.85 | CDK2 (0.63) | MAP4K4IRAK4FLT3GAKRIPK2 | |
| SCHEMBL27045536 | 0.85 | CDK2 (0.63) | MAP4K4IRAK4FLT3GAKRIPK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107382984-B | Preparation method of medicine for treating leukemia | 扬州市三药制药有限公司 | 2020-07-10 | — | — | CN | claimed |
| US-20240025892-A1 | SALT INDUCIBLE KINASE INHIBITORS | THE GENERAL HOSPITAL CORPORATION | 2024-01-25 | — | — | US | disclosed |
| CN-107382983-B | Synthesis method of medicine for treating leukemia | 扬州市三药制药有限公司 | 2020-08-07 | — | — | CN | disclosed |
| CN-107382984-B | Preparation method of medicine for treating leukemia | 扬州市三药制药有限公司 | 2020-07-10 | — | — | CN | disclosed |
| CN-107382984-B | Preparation method of medicine for treating leukemia | 扬州市三药制药有限公司 | 2020-07-10 | — | — | CN | disclosed |
| EP-1641780-B1 | PROCESSES FOR THE PREPARATION OF 1- [(BENZOIMIDAZOLE-1YL) QUINOLIN-8-YL] PIPERIDIN-4-YLAMINE DERIVATIVES | PFIZER PROD INC (US) | 2008-11-12 | — | — | EP | disclosed |
| EP-1641780-B1 | PROCESSES FOR THE PREPARATION OF 1- [(BENZOIMIDAZOLE-1YL) QUINOLIN-8-YL] PIPERIDIN-4-YLAMINE DERIVATIVES | PFIZER PROD INC (US) | 2008-11-12 | — | — | EP | disclosed |
| US-20070088032-A1 | Processes for the Preparation of Benzoimidazole Derivatives | TOM NORMA J | 2007-04-19 | — | — | US | disclosed |
| US-7183414-B2 | Processes for the preparation of benzoimidazole derivatives | PFIZER INC (US) | 2007-02-27 | — | — | US | disclosed |
| US-7183414-B2 | Processes for the preparation of benzoimidazole derivatives | PFIZER INC (US) | 2007-02-27 | — | — | US | disclosed |
| EP-1641780-A1 | PROCESSES FOR THE PREPARATION OF 1- [(BENZOIMIDAZOLE-1YL) QUINOLIN-8-YL] PIPERIDIN-4-YLAMINE DERIVATIVES | Pfizer Products Incorporated (US) | 2006-04-05 | — | — | EP | disclosed |
| US-20050020625-A1 | Processes for the preparation of benzoimidazole derivatives | PFIZER INC | 2005-01-27 | — | — | US | disclosed |
| WO-2004113322-A1 | PROCESSES FOR THE PREPARATION OF 1-[(BENZOIMIDAZOLE-1YL) QUINOLIN-8-YL] PIPERIDIN-4-YLAMINE DERIVATIVES | PFIZER PRODUCTS INC. (US) | 2004-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070088032-A1 | Processes for the Preparation of Benzoimidazole Derivatives | CCNI, CCNT1, CCNE1 | MAP4K4 1296/4885IRAK4 1084/4885FLT3 498/4885 |
| US-20240025892-A1 | SALT INDUCIBLE KINASE INHIBITORS | SGK1, SGK2, SIK1 | MAP4K4 47/4885IRAK4 431/4885FLT3 1688/4885 |
| US-20050020625-A1 | Processes for the preparation of benzoimidazole derivatives | CCNI, CCNT1, CCNE1 | MAP4K4 1379/4885IRAK4 1108/4885FLT3 567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.